400 related articles for article (PubMed ID: 26350296)
21. Impact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study.
Lang ST; Gan LS; McLennan C; Monchi O; Kelly JJP
IEEE Trans Biomed Eng; 2020 Dec; 67(12):3327-3338. PubMed ID: 32286953
[TBL] [Abstract][Full Text] [Related]
22. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Treating Fields: Nursing Implications for an Emerging Technology
.
Chang A
Clin J Oncol Nurs; 2017 Jun; 21(3):302-304. PubMed ID: 28524900
[TBL] [Abstract][Full Text] [Related]
24. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
[TBL] [Abstract][Full Text] [Related]
25. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
Kesari S; Ram Z;
CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
[TBL] [Abstract][Full Text] [Related]
26. Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma.
Lok E; San P; Liang O; White V; Wong ET
J Neurooncol; 2020 Mar; 147(1):125-133. PubMed ID: 31989489
[TBL] [Abstract][Full Text] [Related]
27. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
[TBL] [Abstract][Full Text] [Related]
28. Impact of glioma peritumoral edema, tumor size, and tumor location on alternating electric fields (AEF) therapy in realistic 3D rat glioma models: a computational study.
Nguyen H; Schubert KE; Pohling C; Chang E; Yamamoto V; Zeng Y; Nie Y; Van Buskirk S; Schulte RW; Patel CB
Phys Med Biol; 2024 Apr; 69(8):. PubMed ID: 38417178
[No Abstract] [Full Text] [Related]
29. Temperature control in TTFields therapy of GBM: impact on the duty cycle and tissue temperature.
Gentilal N; Salvador R; Miranda PC
Phys Med Biol; 2019 Nov; 64(22):225008. PubMed ID: 31671414
[TBL] [Abstract][Full Text] [Related]
30. Effects of tissue dielectric properties on the electric field induced in tDCS: a sensitivity analysis.
Salvador R; Ramirez F; V'yacheslavovna M; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():787-90. PubMed ID: 23366010
[TBL] [Abstract][Full Text] [Related]
31. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
32. Tumor Treating Fields: Adjuvant Treatment for High-grade Gliomas.
Anthony P; McArdle S; McHugh M
Semin Oncol Nurs; 2018 Dec; 34(5):454-464. PubMed ID: 30413356
[TBL] [Abstract][Full Text] [Related]
33. A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.
Butowski N; Wong ET; Mehta MP; Wilson LK
Semin Oncol; 2013 Dec; 40(6):S2-4. PubMed ID: 24331200
[TBL] [Abstract][Full Text] [Related]
34. Electric field distributions in realistic 3D rat head models during alternating electric field (AEF) therapy: a computational study.
Nguyen H; Schubert KE; Chang E; Nie Y; Pohling C; Van Buskirk S; Yamamoto V; Zeng Y; Schulte RW; Patel CB
Phys Med Biol; 2023 Oct; 68(20):. PubMed ID: 37703902
[No Abstract] [Full Text] [Related]
35. Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors.
Branter J; Estevez-Cebrero M; Diksin M; Griffin M; Castellanos-Uribe M; May S; Rahman R; Grundy R; Basu S; Smith S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216098
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
Riley MM; San P; Lok E; Swanson KD; Wong ET
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
[TBL] [Abstract][Full Text] [Related]
37. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
38. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
[TBL] [Abstract][Full Text] [Related]
39. Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study.
Korshoej AR; Saturnino GB; Rasmussen LK; von Oettingen G; Sørensen JC; Thielscher A
PLoS One; 2016; 11(10):e0164051. PubMed ID: 27695068
[TBL] [Abstract][Full Text] [Related]
40. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
